From: Consumer input into research: the Australian Cancer Trials website
Data item | Options |
---|---|
Cancer stage | Early |
Locally recurrent or locally advanced | |
Metastatic/Widespread | |
Not applicable | |
Treatment type (s) | Treatment: Hormones |
Treatment: Chemotherapy | |
Treatment: Targeted therapies and biological therapies | |
Treatment: Radiotherapy | |
Treatment: Surgery | |
Treatment: Other | |
Antiemetics | |
Complementary | |
Palliative care | |
Prevention/Screening | |
Psychosocial (counselling/training/communication/education) | |
Lifestyle | |
Rehabilitation | |
State (s) of recruitment | The Australian state (s) where the participants are being recruited |
Anticipated or actual recruitment end date | The anticipated or actual date the trial will stop recruiting patients |
Side effects | The known and possible side effect (s) for each trial arm from most to least common |
Cost to participants | Similar cost as usual care |
Less cost than usual care | |
More cost than usual care | |
Time commitments | Similar time commitment as usual care |
Less time commitment than usual care | |
More time commitment than usual care | |
Lay summary written by a medical writer | Format of summary: |
• An initial sentence summarizing the trial purpose | |
• A section describing the patient eligibility under the heading "Who is it for?" | |
• A section entitled "Trial details" which describes the trial design, intervention(s) and comparator(s) and outcome measures of the trial |